Tempest TherapeuticsTPST
13F holders, Q1 2026 (March 31)21holders +1
2new positions
2sold out
$1.64avg. 13F price*
At the end of Q1 2026, 21 institutions reported holding Tempest Therapeutics Inc. (TPST) in their 13F filings, up 1 from Q4 2025. 2 opened new positions and 2 sold out. The largest holders were Vanguard Capital Management LLC ($384K), Geode Capital Management, LLC ($143K) and Vanguard Fiduciary Trust Co. ($113K).
- Company
- Tempest Therapeutics Inc.
- CUSIP
- 87978U207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $21 |
| Exits | 2 | $30K |
All 13F filers, Q4 2025 → Q1 2026: 44,375 shares bought and 184,313 shares sold, net −139,938 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 21 holders
| Vanguard Capital Management LLC | 0.00% | — | 233,888 | $384K |
| Geode Capital Management, LLC | 0.00% | Add +97.2% | 86,990 | $143K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 68,908 | $113K |
| BlackRock, Inc. | 0.00% | No change | 39,068 | $64K |
| FMR LLC | 0.00% | No change | 33,225 | $54K |
| Sabby Management, LLC | 0.55% | Reduce -90.0% | 17,856 | $29K |
| Northern Trust Corp. | 0.00% | No change | 14,053 | $23K |
| Dimensional Fund Advisors LP | 0.00% | No change | 11,444 | $19K |
| UBS Group AG | 0.00% | Reduce -74.2% | 4,533 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +110.6% | 2,790 | $5K |
| Morgan Stanley | 0.00% | No change | 2,058 | $3K |
| Osaic Holdings, Inc. | 0.00% | Reduce -5.2% | 1,529 | $2K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 292 | $479 |
| Jones Financial Companies LLLP | 0.00% | No change | 239 | $413 |
| Vanguard Global Advisers, LLC | 0.00% | — | 168 | $276 |
| SBI Securities Co., Ltd. | 0.00% | No change | 56 | $92 |
| Parallel Advisors, LLC | 0.00% | No change | 18 | $30 |
| Citigroup Inc. | 0.00% | New | 8 | $13 |
| JPMorgan Chase & Co. | 0.00% | New | 5 | $8 |
| BNP Paribas Financial Markets | 0.00% | No change | 3 | $5 |
| Royal Bank of Canada | 0.00% | Add +237.5% | 27 | $0 |
"% of holder's portfolio" is TPST's weight in each manager's 13F, not the share of Tempest Therapeutics Inc. the manager owns.